Remedor Biomed Overview

  • Founded
  • 2009
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Remedor Biomed General Information


Provider of a biomedical technology platform based on the combination of two naturally-occurring glycoproteints: erythropoietin (EPO) and fibronectin (FN). The company develops a formulation, based on erythropoietin and fibronectin, for therapeutical use in tissue regeneration in the processes of wound healing and bone repair.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Social/Platform Software
Primary Office
  • Ha-Avoda Street 12
  • Nazareth Iliit
  • Israel
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Remedor Biomed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view Remedor Biomed’s complete valuation and funding history, request access »

Remedor Biomed Executive Team (2)

Name Title Board Seat Contact Info
Saher Remedor Ph.D Founder, Chief Technology Officer & Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

Remedor Biomed Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Next Generation Technology Venture Capital Minority 000 0000 000000 0
To view Remedor Biomed’s complete investors history, request access »